NanoString has stated that it is preparing for the commercial launch of its nCounter analysis system. Accelr8 has also announced that Schott Nexterion has purchased an OptiChem license renewal.
The new license enables Schott’s Nexterion product group to continue non-exclusive global manufacturing and marketing of OptiChem-coated microarraying slides. The license follows two previous licenses to Schott.
Both licenses require up-front payment of licensing fees and pre-payment of minimum guaranteed royalties to Accelr8. The licenses provided $200,000 in combined cash payments to Accelr8.
David Howson, Accelr8’s president, said: “We are very pleased that NanoString selected OptiChem coatings for their innovative digital gene expression platform. They have exciting technology for molecular bar-coding, and need OptiChem’s ability to reject background interference while providing high capacity for specific target binding.”